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We performed randomized controlled experimental studies in an intact animal model and in 
isolated cardiac myocytes with the following aims: 
 
Paper I 
To establish an in vivo model for measuring cardiac intracellular [Ca2+] ([Ca2+]i) in an 
anesthetized rat with maintained spontaneous circulation. In this model we could sort out if 
alterations in Ca2+ homeostasis take place in response to hypothermia and rewarming.  
 
Paper II 
To investigate myocardial [Ca2+]i during graded hypothermic exposure-time and after 
rewarming during maintained spontaneous circulation. 
 
Paper III 
To describe the Ca2+ homeostasis in subcellular compartments; if mitochondria buffer 
excessive cytosolic Ca2+ in single beating cardiac myocytes during hypothermia and 
rewarming. 
 
Main results and conclusions 
We established an in vivo model for measuring cardiac cell [Ca2+]i which revealed that cardiac 
Ca2+ overload evolves during long-lasting profound hypothermia, and that the increase in 
[Ca2+]i remains unchanged during rewarming. In vitro mitochondria buffer cytoplasmic [Ca
2+] 
([Ca2+]cyt) during hypothermia (0,5 hs). We conclude that prolonged deep hypothermia alters 
cardiac myocyte Ca2+ handling which may deteriorate mitochondrial function contributing to 
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5.1 Rationale for the thesis 
In Norway, the death rate from accidental hypothermia is estimated to 0,5 deaths per 100.000 
inhabitants per year [1]. Today the poor and elderly, the homeless, people working outside, 
especially in harsh or arctic climate, are at risk [2]. These patients often present with impaired 
cardiac function, cardiac arrhythmias, circulatory shock or even circulatory arrest [3], and 
during resuscitation the mortality rate is ranging between 29% and 80% [4-6]. Thus, the 
consequences of accidental hypothermia may be fatal which makes this a typical low-
frequency but high-impact diagnosis [4]. 
Hypothermia is defined as core temperature below 35ºC [7], and different under-
classifications exist. The European Resuscitation Council uses the following nomenclature: 
mild hypothermia (32ºC - 35ºC), moderate hypothermia (28ºC - 32ºC) and severe/deep 
hypothermia (< 28ºC) [8]. The American Heart Association defines mild hypothermia as 
temperatures above 34°C, moderate between 34-30°C and severe below 30°C based on 
suggestions by Polderman and Herold [9].  
Due to the different severities, variety in aetiology, low incidence, different rewarming 
methods and a relatively sparsely elucidated pathophysiology, few evidence-based treatment 
protocols of accidental hypothermia exist. Hence, the topic of accidental hypothermia should 
be studied to establish a better fundamental physiological understanding on which treatment 
protocols can be based. To achieve this, one needs to investigate both hypothermia-induced 
physiological changes as well as the consequences of rewarming. 
Myocardial Ca2+ homeostasis is known to be affected by hypothermia. In the heart, 
Ca2+ plays a key role in the excitation-contraction coupling and is also involved in regulating 
adenosine triphosphate (ATP) production. In other words, fluctuations of [Ca2+]i are very 
important for the main function of cardiac myocytes, namely; contraction and relaxation, 
which is often altered in victims of accidental hypothermia. Accordingly, we wanted to 
elucidate the impact of severe accidental hypothermia and rewarming on the regulation of 
myocardial [Ca2+]i. This information might also have relevance for mild or moderate 




5.2 Hypothermia-induced cardiac contractile dysfunction 
5.2.1 Categorization of the contractile dysfunction 
Research indicates that during deep hypothermia (3.8 - 16ºC), there is a reduction in cardiac 
contractility [10-15]. By increasing exposure time to stable hypothermia, the deficit in post-
hypothermic cardiac contractile function is aggravated [16, 17]. Specifically, from 
experimental studies in rats, we know that during cooling, there is a decrease of left 
ventricular (LV) end systolic volume and a subsequent increase in stroke volume (SV). 
However, during stable hypothermia a gradual increase in LV end systolic volume is followed 
by a reduction in SV [12, 16]. During the rewarming phase, isovolumetric pressure is 
depressed and ventricular wall shortening is reduced, whereas diastolic function is unaffected 
[16]. Hence, hypothermia-induced cardiac dysfunction is mainly due to compromised systolic 
function. A similar hypothermia-induced depression of systolic function and a reduced SV is 
also demonstrated in hypothermic dogs and pigs [14, 15, 18, 19]. 
In its fulminant form the cardiac contractile dysfunction is recognized as a progressive 
reduction of cardiac output (CO) and a sudden fall in arterial blood pressure [12, 17, 20, 21], 
and thus this is suggested to be a part of the underlying pathophysiology for the impaired 
cardiac function, cardiac arrhythmias, circulatory shock or even circulatory arrest presented in 
hypothermic/rewarmed patients [3].  
 
5.2.2 Mechanisms underlying the contractile dysfunction 
The basic pathophysiology of hypothermia/rewarming-induced contractile failure of the heart 
is poorly investigated. So far, researchers point out increased reactive oxygen species (ROS) 
formation [22, 23], impaired high energy phosphate homeostasis [17] and decreased 
myofilament Ca2+ sensitivity, resulting from increased cTnI phosphorylation [24] as possible 
mechanisms. In addition, results from our group suggest that rewarming following profound 
hypothermia is associated with a myocardial cellular stress response that involves activation 
of nuclear factor κB signalling and induction of autophagy [25]. At last, the hypothermia-
induced contractile failure may be caused by an excessive increase of [Ca2+]i [26]. This is 
explained by the fact that in the hypothermic heart, inhibition of ion transport mechanisms, 
which are involved in Ca2+ regulation, takes place [27-30]. Since Ca2+ is important for 
contraction and relaxation of the myocyte, such a dysregulation of Ca2+ homeostasis should 




5.3 Hypothermia and myocardial [Ca2+]i  
Hypothermia-induced increase of [Ca2+]i has been reported from in vitro experiments using 
isolated cardiac myocytes [31-33] and isolated hearts [13, 28, 34, 35]. In isolated hearts, 
increase in [Ca2+]i does not seem to normalize during rewarming [35]. While most studies 
have been performed in rat hearts, the impact of hypothermia/rewarming on calcium 
concentrations has also been examined in other species with qualitatively similar results. For 
example, in guinea pig hearts where hypothermia (10ºC) was maintained for 40 min, [Ca2+]i 
was reported to be elevated, even more than in rats [36]. Compared with rat, the [Ca2+]i 
handling of guinea pig heart is believed to more closely resemble that of the human heart, and 
hence, this makes it easier to draw lines into human medicine. To the best of our knowledge, 
no data concerning changes in myocardial [Ca2+]i in in-situ hearts subjected to a non-arrested 
hypothermic state, has been reported to date. 
 
5.3.1 Mechanism underlying hypothermia-induced elevation of [Ca2+]i 
The mechanism for hypothermia-induced increase in [Ca2+]i in cardiac myocytes is not fully 
understood but is likely multi-factorial [13]. In cardiomyocytes Ca2+ is best known for its 
central role in excitation contraction coupling. Depolarization along the sarcolemma allows 
Ca2+ in the T-tubules to enter the cell via L-type Ca2+ channels and induce Ca2+ release (43 - 
55%) from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyR) in the dyadic cleft 
(figure 1). Cooling is known to slow down SR function, and an increase in the open 
probability of RyR channels which may contribute to elevated [Ca2+]i. However, this is 
probably not the primary mediator of the hypothermia-induced increase of [Ca2+]i [29]. 
Ca2+]cyt is extruded across the sarcolemma by the Na
+-Ca2+ exchanger (NCX) or the 
plasma membrane Ca2+ ATPase (PMCA) pump. [Ca2+]cyt is also removed by SR reuptake via 
the sarcoplasmic reticulum Ca2+ ATPase (SERCA) pump or mitochondrial Ca2+ uptake 
primarily via the mitochondrial Ca2+ uniporter (MCU) (figure 1). The temperature sensitivity 
of these ion transporters may vary, and thus, an imbalance between ion pump activity and ion 
leaks may cause prolonged elevation of [Ca2+]cyt ([Ca
2+]cyt loading) [37, 38]. It is widely 
believed that cooling increases [Ca2+]cyt by slowing NCX, PMCA and SERCA activities. In 
addition, hypothermia-induced slowing of the Na+/K+-ATPase will increase intracellular Na+ 
concentration and thus activate a reverse mode of the NCX to extrude Na+ in exchange for 




5.3.2 [Ca2+]i and inotropy 
Due to Ca2+ influx, cardiac myofilaments are activated by the total free [Ca2+]cyt, which binds 
to troponin C to activate the thin filament. The degree of contractile activation depends on 
amount of [Ca2+]cyt and the Ca
2+ sensitivity of the thin filament [40]. From experiments 
performed at 37ºC and in room temperature, it is well known that an increase in [Ca2+]cyt 
induces positive inotropy, because it increases thin filament activation and increases Ca
2+ 
sensitivity [13, 29, 41-45]. However, an excessive Ca2+ accumulation will induce negative 
inotropy in the heart, and this is termed Ca2+ overload [46], and is expressed as impaired 
contractility and relaxation, hypercontracture and arrhythmias. 
Initially, cooling increases contractile response (positive inotropy) recognized as an 
elevation of SV in intact rats (20ºC) [16], increase in developed force in rat and rabbit 
ventricular papillary muscle (25ºC) [29] and increased fractional shortening in pig ventricular 
myocytes (22ºC) [32]. This may be because of a hypothermia-induced increase in [Ca2+]cyt 
[45], but an alternative explanation might be the negative staircase effect of the rat heart [16]. 
Deeper hypothermia decreases inotropy [16], and this is regarded as physiological event as 
the metabolic demands decreases with temperature [47]. However, as stated above, in severe 
hypothermic rats cardiac contractile dysfunction is evolving with time and persists with 
rewarming [15, 16]. Such negative inotropic effect is also observed in human atrial myocytes 
during moderate hypothermia as decreased twitch tension (rapid cooling, 31ºC) [48], in hearts 
from intact dogs (as reduced LV dP/dtmax, CO and SV at 25ºC) [14], and in Langedorff 
perfused (10ºC) rat and guinea pig hearts (increased LVEDP) [36]. Hypothermia-induced 
Ca2+ overload is suggested to be one of the mechanisms underlying these observations [36, 
48]. However, simultaneous measurements of intracellular [Ca2+] and cardiac contractility 
during hypothermia and rewarming in vivo have not been performed.  
The different inotropic responses to hypothermia fit the paradoxical effects of 
increased [Ca2+]cyt, and support our hypothesis that an increase of [Ca
2+]cyt (Ca
2+ overload)  
underlies the contractile dysfunction. Moreover, studies indicate that severity of hypothermia 
and exposure-time are decisive factors for the inotropic response. In addition, different 
responses between species substantiate the fact that Ca2+ handling and response to cooling is 








Figure 1: The excitation-contraction coupling and cycling of Ca2+. From Bers 2002 [39]. 
 
5.4 The role of mitochondria 
In mitochondria, Ca2+ takes part in regulating intra-mitochondrial oxidative metabolism and 
production of ATP (figure 2). Increased workload in the heart increases cytosolic calcium 
which leads to an elevated mitochondrial matrix calcium. Thus mitochondrial Ca2+ serves to 
couple the increase in work to increase in ATP production that is needed to sustain the work 
[49]. The mitochondrion also has an important role in Ca2+ buffering since it is capable of 
sequestering considerable amonts of Ca2+ by forming Ca2+ phospate complexes [50] (table 1). 
This buffering effect is observed at physiological conditions such as changed heart rate and/or 
changed workload and under unphysiological conditions with higher [Ca2+] [51]. 
Details of how Ca2+ enters the mitochondria is not completely settled; Ca2+ enters the 
mitochondrial matrix, driven by its electrochemical gradient, through the MCU. In addition, 
the leucine-zipper-EF-hand-containing transmembrane protein 1 (LETM 1) may also be 
participating in Ca2+ influx [49, 51] (figure 2). 
The Na+-Ca2+-Li+ exchanger (NCLX) is the most important mechanism for extrusion 
of [Ca2+]mit using the influx of sodium down its electrochemical gradient [49, 52]. In addition, 
to limit excessive accumulation of matrix Ca2+ the mitochondrial permeability transition pore 
(MPTP) might act as a Ca2+ release valve [51, 53, 54]. Opening of the MPTP is suggested to 
be activated by cellular stress (i.e. high [Ca2+]i and [ROS]i) [55]. Opening leads to increased 
permeability of the inner mitochondrial membrane to large molecules. Thus prolonged 
opening consequently results in degradation of the inner mitochondrial membrane potential 





Figure 2: Mitochondrial metabolism components. Red arrows indicate Ca2+ 
interactions/pathways, and enzymes with known Ca2+ sensitivities are red. The five complexes 
responsible for oxidative phosphorylation are light blue ovals. Pyruvate dehydrogenase 
(PDH); citrate synthase (CS); aconitase (A); isocitrate dehydrogenase (ICD); a-ketoglutarate 
dehydrogenase (KDH); succinyl CoA synthetase (SCS); succinate dehydrogenase (SDH); 
fumarase (F); malate dehydrogenase (MDH); mitochondrial Ca2+ uniporter (MCU); 
mitochondrial Na+/Ca2+ exchanger (NCLX); Leucine zipper-EF-hand containing 
transmembrane protein 1 (Letm1); cytochrome C (C); ubiquinone (Q); voltage-dependent 
anion channel (VDAC); ATP/ADP translocase (ANT); inorganic phosphate carrier (PiC); 





Localization [Ca2+] (µM = µmol/L of cytosol) 
Extracellular 1000 µM (free) 
Cytosol 0,15/1,00 µM (diastole/systole) (free) 
Dyadic cleft 10 -100 µM (free) 
Ca2+ hot spots/microdomains 50 - 100 µM (free) 
Sarcoplasmic reticulum 100 µM (total) 
Mitochondria 100 - 10 000 µM (total) 
Table 1: Values of [Ca2+] (µM = µmol/L of cytosol) in a cardiac myocyte [40, 59]. 
 
5.4.1 Observations in the hypothermic/rewarmed mitochondria 
Although there is considerable information regarding basal mitochondrial function at room 
temperature (equivalent to severe hypothermia) and protective effects of therapeutic 
hypothermia, few have focused on the actual effects of cooling in this organelle. Riess et al. 
have reported that hypothermia induces an increase of [Ca2+]mit in cold perfused isolated 
hearts (17ºC, 50 min) which reverses with rewarming [60]. During hypothermia (13-15ºC) 
and rewarming in vivo, and during hypothermia in vitro, decreased ATP production, increased 
ROS generation and damaged mitochondrial ultrastructure have been reported [16, 22, 60]. 
These observations encouraged us to have a closer look at the Ca2+ dynamics between the 
mitochondria and cytosol.  
 
5.4.2 Possible consequences of altered mitochondrial Ca2+ homeostasis 
According to observations by Riess et al., and the fact that [Ca2+]cyt in vitro rises with cooling, 
it is likely that mitochondria buffer the excessive [Ca2+]cyt, and at some point [Ca
2+]mit 
overload may occur.  [Ca2+]mit is a critical regulator of  mitochondrial function [61] and 
mitochondrial calcium overload is a primary trigger of necrotic cell death [62]. Suggested 
mechanisms behind mitochondrial dysfunction and cell death are mitochondrial 
depolarization, uncoupling of oxidative phosphorylation, decreased ATP synthesis, ROS 
generation and mitochondrial swelling [40, 56-58, 63-70]. If these events take place during 
hypothermia/rewarming, the contractile function of the cardiac myocyte will be affected. We 
hypothesized that hypothermia/rewarming-induced myocardial contractile failure may arise 
from mitochondrial Ca2+ buffering of excessive [Ca2+]cyt  which results in perturbation of 
mitochondrial function through the same mechanisms as listed above. To the best of our 
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knowledge, simultaneous measurements of [Ca2+]cyt and [Ca
2+]mit in single cardiac myocytes 




6. Aims of the thesis 
The central goal of the present thesis was to shed light on the aspects of myocardial Ca2+ 
handling at low temperatures which may be crucial to cardiac function and force development 
during hypothermia and rewarming. To achieve this, we intended to measure cardiac [Ca2+]i 
in intact animals with spontaneous circulation, and measure [Ca2+]cyt and [Ca
2+]mit in 
electrically stimulated single cardiac myocytes during hypothermia and rewarming. 
 
The specific aims of the present study were as follow:  
 
6.1 Paper I 
To establish an in vivo model for measuring cardiac [Ca2+]i in an anesthetized rat with 
maintained spontaneous circulation. In this model we could sort out if alteration in Ca2+ 
homeostasis takes place in response to hypothermia and rewarming  
 
6.2 Paper II 
To elucidate changes in myocardial [Ca2+]i during graded hypothermic exposure-time during 
maintained spontaneous circulation. 
 
6.3 Paper III 
To investigate the Ca2+ homeostasis in subcellular compartments; if mitochondria buffer 




7. Methods and methodological considerations 
7.1 Choice of animal species 
The rat was chosen as experimental animal in all studies. In vivo studies have shown that this 
animal maintains spontaneous electromechanical cardiac activity down to about 13ºC, and it 
is less susceptible to arrhythmias compared to larger animals during hypothermic exposure 
[71]. The in vivo rat model is well established and have successfully been used on our 
laboratory for hypothermic research for years [16, 16, 47, 72-74, 74, 75, 75] making it a 
reliable and reproducible experimental animal model. This anesthetized, intact animal model 
of accidental hypothermia needs minimal surgical intervention, and at the same time it offers 
the possibility to sample a wide range of hemodynamic, as well as laboratory, variables.  
The advantage obtained when using isolated cells, lies in the possibility to isolate the 
aspects of cooling and rewarming to the cardiac myocyte alone. There are no hormonal or 
neuronal influences or coronary flow that needs to be considered. However, in isolated cells 
the possible regulations that occur between myocytes, endothelium, intercellular space, 
cardiac lymph and plasma are not present. This makes the isolated cell model a comparative 
reductionist model that cannot mimic all aspects of hypothermia. Many experiments in 
cardiac myocytes are conducted at room temperature (deep hypothermia). In one aspect, this 
makes it easier to compare our results from hypothermia with other studies on rat cardiac 
myocytes. On the other hand, to compare results with studies describing basic cellular 
functions at room temperature without normothermic “controls”, might bias our conclusions. 
Extrapolation of data obtained at the single cellular level, or isolated hearts, to the intact 
heart should be done with caution. In addition, previous studies suggest species-dependent 
differences in SR function and cellular responses to hypothermia [29, 76]. Again, one should 
be careful making conclusions for human from rat experimental models. 
 
7.2 In vivo experiments (paper I and II) 
7.2.1 Instrumentation and measurements of hemodynamic variables 
All experimental protocols were approved by Norwegian Research Authority and conducted 
on anesthetized male Wistar rats according to European Convention for the Protection of 
Vertebrate Animals used for Experimental and Other Scientific Purposes (Strasbourg, 
18.III.1986). 
Anesthesia was introduced intraperitoneally by 55 mg/kg body weight pentobarbital 
sodium and fentanyl 50 μg/kg body weight, followed by a continuous infusion of 7,5 
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mg/kg/hour pentobarbital sodium and 50 μg/kg/hour fentanyl through an intravenous (i.v.) 
line in the right jugular vein extended to the right auricle. In the hypothermic groups the 
infusion was terminated when cooling was started due to hypothermia created anesthesia and 
reduced drug metabolism, and reinstituted during rewarming at 34 - 37ºC. The normothermic 
group was given anaesthesia during the whole experiment. The animals were monitored by 
toe-pinch for any signs of discomfort. This is a well-established method for testing the effects 
of analgesic drugs in rodents and has been extensively tested in rats[77]. 
 Both pentobarbital and fentanyl potentially affect the cardiovascular system by 
lowering blood pressure and inducing bradycardia. In addition, they may depress respiration. 
The doses used were standardized, and from our experience with this model, these side-effects 
are not a problem. However, in addition to monitoring blood pressure, we also analysed blood 
gasses.  
The rat was placed on the operating table in a supine position. The trachea was opened 
and a tracheal tube inserted. All animals had spontaneous and sufficient ventilation at core 
temperatures above 20ºC. At core temperatures below 20ºC normoventilation was achieved 
by a volume-controlled small animal respirator using room air. 
Mean arterial pressure (MAP) was continuously monitored through a fluid filled 
catheter introduced into the left femoral artery. LV pressure was measured through a fluid-
filled catheter (20 G) placed in the left ventricle via the right common carotid artery. LV 
pressure was differentiated to obtain the maximum rate of rise in LV pressure (LV dP/dtmax). 
Catheters were connected to transducers, and the signals from the pressure transducer were 
amplified to 0 - 10 V and passed to a 12-bit analogue to digital converter. Signal processing 
and analysis were performed with the help of a special computer program developed at our 
department using a commercially available software package. Right atrium was catheterized 
through the right external jugular vein and used for injection for cardiac output (CO) 
measurements (thermodilution technique) and anesthesia infusion. A thin thermocouple, 
connected to a thermocouple controller was positioned in the aortic arch through the right 
femoral artery to monitor core temperature and temperature changes during CO 
measurements. Skin wounds were thereafter sutured and heat-exchanging tubes were placed 
in oesophagus and lower bowels. 
 
7.2.2 Core cooling and rewarming 
The animals in the hypothermic groups were cooled and rewarmed by circulating cold or 
warm water through U-shaped polyethylene tubes placed in oesophagus and lower bowels. In 
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addition, the double-layered operating table made of hollow aluminium was circulated by 
temperature-adjusted water. Core temperature was continuously monitored using the 
thermocouple wire positioned in the aortic arch via right femoral artery, connected to the 
thermocouple controller. Cooling lasted about 60 min, while rewarming lasted about 120 min. 
 
7.2.3 Cardiac output measurements 
CO was measured by thermodilution technique [78] which is reported to a be a reliable 
method also at low temperatures [79, 80]. One must take in to account that CO measured by 
thermodilution technique in small animals, especially at low flow, could be overestimated [79, 
81, 82] due to the greater heat diffusion in these animals. However, by maintaining a constant 
room temperature and comparing CO at same core temperatures during cooling and 
rewarming in the same animal, we have eliminated the influence of this error.  
We injected saline (0,1 – 0,15 ml) pre-cooled in ice water through the i.v. line 
positioned in the right auricle. Change in temperature was recorded from the thermocouple 
positioned in the aortic arch through the right femoral artery. Thermodilution curves were 
recorded on a Linearcorder. These curves were digitalized with a digitizing table, and CO was 
calculated with a program designed with the LabView package.  
 
CO = (Tblood – Tinj) × Volinj × 60/A × Yres × Xres 
 
Tblood -blood temperature (ºC), 
Tinj -temperature of the injected saline (ºC), 
Volinj -volume of the injected saline (ml), 
A -area under the curve (mm2), 
Yres -resolution of y-axis (ºC/mm) and  
Xres -resolution of x-axis (sec/mm). 
 
CO was calculated as mean of three consecutive measurements. 
 
7.2.4 Blood gases measurements 
Blood gases, oxygen saturation, pH  and [Ca2+] were measured in 0,15 ml arterial blood 
samples taken from femoral artery after surgery (37ºC), at 15ºC and after rewarming to 37ºC 
in the hypothermic group and three times in normothermic control group (at baseline and after 
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3 and 5 hs at 37ºC). Samples were analysed by a blood gas analyser. In accordance to the 
advice of Ashwood et al., the results were not temperature corrected (pH-stat), meaning we 
used the alpha-stat method [83]. The blood gasses data are presented in paper II only. 
 
7.2.5 Measurements of [Ca2+]i in hearts 
To measure [Ca2+]i the technique of using radiolabelled Ca
2+ (45Ca2+) [84] was adapted to in 
vivo use. This method cannot distinguish between intracellular pools of Ca2+, and 
consequently only total [Ca2+]i was measured. Calculations of [Ca
2+]i are based on measured 
concentrations of Ca2+ in plasma and concentrations of 45Ca2+ in plasma and in heart tissue 
(specific radioactivity). For use in intact animals some adjustments in the technique were 
necessary. Specifically, in an intact animal model, in contrast to isolated hearts where isotopes 
in the perfusate equilibrates in heart tissue within less than 1 min [84], a significant time 
interval is necessary after intravascular injection to equilibrate the distribution of 45Ca2+ 
throughout the body. In pilot experiments, 45Ca2+ was measured in blood samples collected 
from several minutes to several hours after injection of 45Ca2+. During the first minute after 
injection, a rapid decline in 45Ca2+ activity was observed. Stable levels were achieved before 2 
hours after time of injection, and 2 hours were considered adequate to achieve equilibrium of 
45Ca2+ distribution in the tissues. During the experimental protocol 20 μCi of 45Ca2+, diluted in 
0,5 ml saline, was injected via the catheter introduced to the left-ventricle catheter after 
instrumentation was completed. 
Before termination of experiments, arterial blood samples were drawn to obtain 
specific activity and concentration of 45Ca2+ and total Ca2+. At the end of experiment, hearts 
were exteriorized through a sternotomy and then immediately perfused in a Langendorff 
system over 3 min with Krebs-Henseleit bicarbonate buffer at room temperature to wash out 
extracellular 45Ca2+. 
In pilot experiments hearts were perfused by this procedure for 15 min and samples of 
the coronary effluent containing 45Ca2+ were collected following few seconds to several 
minutes to obtain 45Ca2+ activity from the extracellular space. We found that already after 1 
min, 45Ca2+ activity in the coronary perfusate decreased to a level that remained unchanged 
during the next 4 to 14 min. This corresponds with data from Tani and Neely who described 
t1/2 for 
45Ca2+ washout to be about 4 seconds [85]. From these experiments, a 3 min washout 
period was decided to be used. 
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The total myocardial [Ca2+]i was expressed as µmol/g dry tissue and found by 
assuming that specific radioactivity 45Ca2+-total Ca2+ ratio for heart and plasma were the same 
([SpR]plasma/[Ca
2+]plasma = [RR]heart/[Ca
2+]i). In order to determine the specific activity of the 
isotope in plasma, an arterial blood sample (1 ml), drawn immediately before terminating the 
experiment, was centrifuged for 5 min at 10000 rpm, and specific radioactivity in plasma 
([SpR]plasma) was measured by using a liquid scintillation spectrometer in 10 ml of scintillation 
fluid with addition of 0,1 ml plasma. Plasma Ca2+ concentrations ([Ca2+]plasma) in the same 
samples were determined using the blood gas analyser. 
After washout of extracellular 45Ca2+, hearts were quickly freeze-clamped with metal 
clamps precooled in liquid nitrogen, and the hearts were dried and homogenated. Thereafter, 
80-90 mg of tissue homogenate was extracted in 1 ml ice-cold 0.42 M perchloric acid for 10 
min and then centrifuged for 10 min at 3000 rpm. The residual intracellular 45Ca2+ was 
counted by a liquid scintillation spectrometer in 5 ml of scintillation fluid with addition of 0,2 
ml of homogenate extract. The [Ca2+]i was calculated as follows:  
 
[Ca2+]i = [RR]heart × [Ca2+]plasma / HW × [SpR]plasma  
 
[RR]heart - residual specific radioactivity in heart tissue after washout of extracellular 45Ca2+, 
[CPM/ml] 
[Ca2+]plasma - plasma concentration of Ca2+, [µmol/ml] 
HW - weight of heart tissue homogenate extracted in 1 ml of perchloric acid, [g/ml] 
[SpR]plasma - the specific plasma radioactivity, [CPM/ml] 
 
 
7.3 In vitro experiments (Paper III) 
7.3.1 Dissociation of cardiac myocytes 
Adult male Sprague-Dawley rats were injected intramuscularly with ketamine (60 mg/kg) and 
xylazine (2,5 mg/kg) for anesthesia. Hearts were exteriorized through a sternotomy, and 
cardiac myocytes were enzymatically dissociated using a Langendorff perfusion-based 
technique with oxygenated Tyrodes solution containing 1,2 mM CaCl2, followed by a Ca
2+ 
free Tyrode solution with 10,0 mM creatinine and 20,0 mM taurine. Cardiac myocytes are 
susceptible to the enzymatic digestion process, and hence to avoid Ca2+ overload, a Ca2+ free 
buffer was used. After 5 min, 0,2 mM CaCl2, 0,6 mg/ml Type II Collagenase and 0,1 mg/ml 
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protease with 1% bovine serum albumin (BSA) were added to stabilize the enzymes and 
increase protein solubility. 
 The Ca2+ concentration was progressively increased in graded steps to 1,2 mM. After 
the heart tissue was sufficiently digested by the enzymes, the LV was excised, scissor-minced 
and gently triturated to obtain single myocytes in fresh Tyrodes solution containing 2% BSA. 
 
7.3.2 Loading with fluorescent Ca2+ indicators 
Enzymatically-dissociated cardiac myocytes were loaded simultaneously with 5 M rhod-
2/AM and 5 M fluo-3/AM in 1,2 mM Ca2+ Tyrodes solution for 45 min at room temperature 
in a dark room. Loading dyes at room temperature is a compromise between the fact that 
processing of AM-esters by esterases increases with temperature. However, by increasing 
temperature some cell types actively endocytose material from the incubation medium in to 
organelles by vesicular traffic [86]. Fluo-3 is mainly loaded to the cytosol. 
 Following incubation, cells were washed and placed in a two-coverslip based closed 
perfusion chamber equipped with stimulating electrodes. Ca2+ tolerance and cell viability 
were evaluated by the absence of plasma membrane blebs and spontaneous [Ca2+]cyt waves 
and oscillations (with only infrequent spontaneous contractions). Cells that displayed 
spontaneous contractions, and/or did not maintain an elongated morphology, were excluded 
from further analysis.  
 Loading with AM ester, up to 80 % of the intracellular rhod-2, a hydrophobic organic 
cation with a delocalized positively charged structure, loads over the mitochondrial membrane 
into the mitochondrial lumen which are both negatively loaded. In mitochondria, cleavage of 
AM ester groups by esterases liberates the Ca2+ sensitive form of rhod-2 (bearing multiple 
nondelocalized negative charges) which is not membrane permeant and thus trapped in the 
mitochondrial lumen. This way, compartmentalization of rhod-2 can be used to monitor 
intramitochondrial Ca2+ signals. However, we have to take into account that the membrane 
permeant AM-esters never loads to only one compartment [86]. In a small set of experiments, 
the intracellular localization of rhod-2 was compared to MitoTracker Green to verify 
mitochondrial loading of rhod-2. Confocal microscopy of cells co-loaded with MitoTracker 
Green and rhod-2 was achieved using a laser scanning confocal microscope system with 
argon (488 nm) and solid state (561 nm) lasers. Images were captured and then pseudo-
colored and analyzed. The pattern of rhod-2 fluorescence was predominantly within 
mitochondria compared to cytosolic areas with no MitoTracker Green fluorescence (figure 1, 
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paper III). In a second set of experiments, the distinction between [Ca2+]cyt and [Ca
2+]mit was 
also confirmed by exposing the cardiac myocytes to a mitochondrial uncoupler, carbonyl 
cyanide m-chlorophenyl hydrazone (CCCP), which prevents[Ca2+]mit accumulation. Exposure 
of cardiac myocytes to CCCP resulted in reduced rhod-2 fluorescence (indicating that these 
signals were primarily of mitochondrial origin), but increased fluo-3 fluorescence (reflecting 
[Ca2+]cyt elevation). 
  
7.3.3 Imaging with confocal laser scanning microscopy 
To measure cytosolic and mitochondrial Ca2+ concentrations ([Ca2+]cyt and [Ca
2+]mit), we 
imaged fluo-3 and rhod-2 fluorescence using confocal laser scanning microscopy (CLSM). 
Fluorescence microscopy (epi-fluorescence) differs from most traditional microscopic 
techniques in that the visible light in the microscope eyepieces is not the original light emitted 
by the light source. The light you see is actually fluorescence emitted at specific wavelengths 
from a fluorophore (e.g., fluo-3 emitted at 525 nm, and rhod-2 emitted at 581 nm) within the 
cardiac myocytes after activation by a specific laser wavelengths (e.g., fluo-3 excited at 488 
nm and rhod-2 excited at 552 nm) [87]. 
Confocal, as in CLSM, means that the illuminating and fluorescent lightpaths have the 
same focus. This can be achieved by different methods, but commonly a pinhole aperture is 
used to limit divergent light, and a dichroic mirror produces a sharp, intense point of 
illumination at a specific depth within the myocytes. The optical section thickness is 
determined by the combination of the pinhole dimension and the numerical aperture of the 
objective lens. A second dichroic mirror processes the fluorescent light from the specimen 
(myocytes) and allows only light information from the illuminated point to reach the detectors 
[88] (fig. 3). This way, confocal microscopy produces images in which out-of-focus 
fluorescence is eliminated. Electrical stimulation and superfusion does not interfere with 
confocal imaging [88]. 
The source of the illumination light is a laser. This light is an intense monochromatic 
light with low divergence, a property that optimizes the effectiveness of the confocal light 
path. Monochromaticity of the light source eliminates chromatic aberration/refraction of 






Figure 3. Principles of confocal laser scanning microscopy (CLSM). From www.thorlabs.de 
[89]. 
  
In general, fluorescent Ca2+ indicators can be excited at wavelengths ranging from UV 
to infrared, including the wavelengths encompassing visible light. The advantages of visible-
wavelength Ca2+ indicators are less cytotoxicity and their emissions are in regions of the 
electromagnetic spectrum where cellular autofluorescence and background scattering are less 
severe. Rhod-2 and Fluo-3 are excited by visible light and have excitation-emission 
wavelengths that do not interfere which make them suitable to monitor cytosolic and 
mitochondrial [Ca2+] simultaneously [86]. Fluo-3 is one of the most suitable visible-
wavelength Ca2+ indicators for CLSM with a Kd for Ca
2+ estimated to be 390 nM which 
corresponds with physiologic [Ca2+]cyt levels [90]. Fluo-3 enhances its fluorescence 40 fold 
upon binding Ca2+ [88]. Rhod-2 has a Kd for Ca
2+ at 570 nM, and its fluorescence enhances on 
binding Ca2+ by 100 fold [90]. The Kd of rhod-2 and fluo-3 are quite low, hence these probes 






 Fluo-3 and rhod-2 are sensitive to photobleaching [92]. However, problems 
associated with excessive illumination were obviated in the present study by the use of the 
VisiTech Eye real-time confocal system, which employs an optical scanning system that has a 
very short dwell time for laser illumination. Furthermore, cells were illuminated only during 
limited data recording periods in order to minimize phototoxicity and photobleaching. 
Fluo-3 and rhod-2 are high affinity Ca2+ indicators, and hence they also work as Ca2+ 
buffers [92]. In other words, since dyes must bind Ca2+ in order to report its concentration, 
they can perturb the true level of [Ca2+]i. This may also change the intracellular environment 
[93]; for example, the regulation of [Ca2+]i are controlled by the free [Ca
2+]. Especially, 
during rapid changes of [Ca2+], the buffering effect of a present Ca2+ indicator becomes more 
apparent [94]. In the present work temperature changes might induce such a rapid change. To 
avoid excessive buffering of [Ca2+]i we limited the concentrations of fluo-3AM and rhod-
2AM during loading.  
In our experiment normal Tyrodes solutions containing 137 mM NaCl, 5,4 mM KCl,  
0,5 mM MgCl2, 1,2 mM CaCl,  0,33 mM NaH2PO4, 10,0 mM HEPES, 10,0 mM glucose (pH 
adjusted to pH 7,38 at 27ºC) was perfused at 1 ml/min. The [Ca2+]cyt and [Ca
2+]mit responses 
of 2 - 3 myocytes per coverslip were obtained using individual, software-defined regions of 
interest (20*20 µm). Cells were visualized at 400X (40X/1,3 oil-immersion lens; 640 x 480 
pixels per frame; 30 frames s-1, optical section thickness of 1 µm). Since the experimental 
protocols were fairly lengthy, cells were excited only during data recording.  
 
7.3.4 Measurements of fluorescence 
Fluo-3 and rhod-2 are non-ratiometric dyes and hence fluorescence intensities cannot be 
exactly calibrated to provide quantitiative estimates of [Ca2+]cyt and [Ca
2+]mit. This also make 
[Ca2+] measurements susceptible to errors stemming from changes in dye concentration and 
motion artifacts [91]. 
 Calibration experiments were performed in order to interpret the measurement of 
fluorescent indicators fluo-3 and rhod-2 during temperature changes. This was accomplished 
by exposing the salt form of each dye (rhod-2 tripotassium salt and fluo-3 pentapotassium 
salt) to a range of free [Ca2+] solutions at three temperatures (17, 27 and 37ºC), two pH levels 
(7.2 and 7.4) and a constant ionic strength (150 mM). The fluorescent levels associated with 
each [Ca2+] was measured using a benchtop fluorometric plate reader. The dissociation 
constant (Kd) was calculated for each Ca
2+ curve by finding the x-intercept of the double log 
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plot of free [Ca2+] versus fluorescence ratio. The fluorescent intensity of rhod-2 and fluo-3 
increased during hypothermia due to a decrease in Kd during transition from 37ºC to 17ºC. 
The Kd of Rhod-2 decreased by 6,7% at 27ºC and 42% at 15ºC while the Kd of fluo-3 
decreased by 14,4% at 27ºC and 35% at 15ºC. Therefore, fluorescence measurements during 
hypothermia were scaled accordingly by the proportional change in Kd (relative to 37ºC) at 
each temperature.  
 
7.3.5 Temperature control 
Accurate temperature control of the cell suspension was achieved by heating/cooling the 
water jacket surrounding the cell chamber, as well as heating/cooling the perfusion tubing 
close to where it entered the cell chamber, using a thermostat controlled perfusion water bath. 
Temperature was continuously monitored with a thermocouple wire, placed right next to the 
water jacket surrounding the cell chamber and connected to a digital thermometer. In pilot 
experiments, temperature stability and consistency of changes were verified.   
 
7.3.5 Electrical stimulation 
Myocytes were electrically stimulated via a stimulator attached to the platinum wires within 
the cell chamber. Twitch stimulation was performed at a constant rate of 0,5 Hz, using single 
pulses of 5 ms duration and voltages ranging from 4 - 7 V.  This stimulation rate is equivalent 
to 30 bpm in normal tissue and was chosen because the spontaneous pacing rate in isolated 





7.4 Experimental protocols 
7.4.1 Paper I, [Ca2+]i after hypothermia and rewarming 
Animals were divided into two groups; one hypothermic group (n = 7) cooled to 15ºC, 
maintained at 15ºC for 4 hs and then rewarmed to normothermia, and one normothermic 
control group (n = 7), kept for 5 hs at 37ºC, which served as control. 45Ca2+ was given two 
hours before baseline measurement. 
Hemodynamic measurements: In the hypothermic group, hemodynamic variables were 
measured at 37ºC, 30ºC and 20ºC during cooling and rewarming, and every hour during stable 
hypothermia. In the control group, measurements were sampled every hour. 
Blood gas measurements: In the hypothermic group blood gases were measured after 
instrumentation, after cooling to 15ºC and after rewarming to 37ºC. In normothermic controls 
blood gases were measured at baseline and after 3 and 5 hs.  
[Ca2+]i measurements: Before termination of the experiment, a blood sample was taken to 
measure [Ca2+]plasma and [
45Ca2+] plasma. The experiment was terminated by excising the heart 
which immediately was prepared for measurements of [45Ca2+]i. 
 
7.4.2 [Ca2+]i during hypothermia and after rewarming, paper II 
Animals were divided into four groups – one hypothermic group kept at 15ºC for 30 min, a 
second hypothermic group kept at 15ºC for 4 hs, a rewarmed group following 4 hs at 15ºC 
and a time matched control group kept at 37ºC for 5 hs. 45Ca2+ was given two hours before 
baseline measurement. 
Hemodynamic measurements, blood gas measurements and [Ca2+]i measurements were the 
same as in paper I. 
 
7.4.3 Paper III, mitochondrial and cytosolic Ca2+ signals during hypothermia and rewarming 
Cell stability was verified over a 15 min period of electrical stimulation (room temperature). 
All experiments started at a temperature of 37ºC. The temperature was changed in the 
following steps as [Ca2+]cyt and [Ca
2+]mit transients were recorded: 37ºC (regarded as control 
temperature for reference), 27ºC (towards cooling), 15ºC (hypothermia temperature; 
maintained for 30 min), 27ºC  (towards rewarming) and 37ºC (rewarmed temperature). In 
order to achieve exact temperature of cells at each step, cells were allowed to stabilize for a 2-
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3 min before recording [Ca2+]cyt and [Ca
2+]mit transients. Total time of one experiment was 
about 180 min. 
For each recording, baseline [Ca2+]cyt and [Ca
2+]mit were measured. Transient [Ca
2+]cyt 
and [Ca2+]mit  responses evoked by electrical field stimulation were analyzed from a series of 
10 twitch responses per set. From the 10 twitch responses, average peak of the evoked 
[Ca2+]cyt and [Ca
2+]mit were determined as well as the average amplitude (peak minus 
baseline) of these responses (figure 2, paper III). The average time to the peak of the evoked 
[Ca2+]cyt and [Ca
2+]mit responses was also measured as well as the average time to 50% decay 
of evoked [Ca2+]cyt and [Ca




Differences between in vivo groups (paper I and II) were compared using two-sample 
independent Student’s t-test. Hemodynamic changes within one group were assessed in the 
cooled and rewarmed group by One-Way ANOVA. 
Data from individual cardiac myocytes (paper III) were averaged and statistical 
comparisons were performed across different time points during hypothermia and rewarming 
using a One-Way ANOVA. 10 cardiac myocytes, obtained from at least 5 animals, were 
analyzed. 




8. Summary of results 
8.1 Paper I 
In this paper we compared changes in hemodynamic function during profound long lasting 
hypothermia, 4 hs 15ºC, and total intracellular Ca2+ ([Ca2+]i) after rewarming to time-matched 
normothermic controls. 
 
8.1.1 Myocardial [Ca2+]i 
Myocardial [Ca2+]i from the hypothermic/rewarmed rats was 3,01 ± 0,43 µmol/g dry weight 
which is almost a seven fold elevation compared to normothermic controls were myocardial 
[Ca2+]i was 0,44 ± 0,05 µmol/g dry weight (figure 3, paper I). These data are comparable to 
values obtained in normothermic in vitro experiments [36]. 
 
8.1.2 Hemodynamics 
With respect to hemodynamics, stability of the model was confirmed as no alterations were 
measured during 5 hs of experiments in the normothermic control group. During cooling there 
was a reduction of most hemodynamic variables, as shown in numerous previous experiments 
during similar conditions [15, 16, 96]. After 4 hs at 15ºC, mean arterial pressure (MAP) and 
left ventricular systolic pressure (LVSP) were reduced by 65 - 70%, whereas heart rate (HR) 
and maximum rate of rise in left ventricular pressure (LV dP/dtmax) were reduced to 13 and 4 
% respectively, compared to their pre-hypothermic baseline values. Due to technical 
limitations, we were not able to measure cardiac output (CO) below 20ºC. At 20ºC, CO was 
reduced by 38%. Total peripheral resistance (TPR) was increased by almost 30%, while 
stroke volume (SV) was increased almost three-fold at 20ºC (figure 1 and 2, Paper I). 
Hemodynamic function following rewarming was compared to pre-hypothermic 
values; after rewarming CO and SV were both significantly reduced to 77% of baseline 
values, while TPR was increased by 28%. LVSP and LV dP/dtmax were reduced to 91% and 
83%, respectively, but did not reach statistical significance. HR and MAP, returned to 






8.2 Paper II 
In this paper we studied changes in [Ca2+]i and hemodynamic function during profound 
hypothermia for 0,5 and 4 hs at 15ºC, and after rewarming. 
 
8.2.1 Myocardial [Ca2+]i 
In the group maintained at 15ºC for 0,5 h [Ca2+]i was 0,55 ± 0,10 μmol/g dry weight which 
was not statistically different from normothermic control levels, 0,35 ± 0,06 µmol/g dry 
weight, after 5 hs. The hypothermic value is five to six times below values from studies done 
in isolated hearts exposed 10ºC for 40 min [28, 35, 36] (table 2). In the group maintained at 
15ºC for 4 hs, [Ca2+]i was 2,33 ± 0,53  μmol/g dry weight, which is more than a six fold 
increase compared to the normothermic control group. In the post-hypothermic group, 
following 4 hs at 15ºC, [Ca2+]i was 1,97 ± 0,38 μmol/g dry weight, which is almost a six fold 




Stability of the model, with respect to hemodynamics, was confirmed as no alterations were 
measured during 5 hs of experiments in the normothermic control group. 
Cooling to 20ºC reduced CO and cardiac power output (CPO) by 37% and 70% 
respectively. TPR was decreased by 34%, whereas SV was almost three-fold increased.  
Subsequent cooling to 15ºC continued to reduce MAP and LVSP by 75 - 80%. HR and LV 
dP/dtmax were 14% and 6% respectively of their normothermic values. At 15ºC 0.5 h, 
hemodynamic parameters were unchanged from corresponding values at 15ºC 0 min. At 15ºC 
4 hs, MAP, LVSP, LV dP/dtmax, LV dP/dtmin were all significantly lowered, 21 - 50% 
compared with 15ºC 0h. 
Following 4 hs at 15ºC and then rewarmed to 20ºC, CO, COP and SV were all 
significantly reduced compared their corresponding values during cooling. When rewarming 
was completed, CO, COP and SV were all significantly reduced from baseline values (start of 
experiment). TPR was increased by 60% from baseline values. HR and MAP returned to pre-
hypothermic levels. LVEDP remained unchanged during the experiments. The contractility 
index dP/dtmax remained lower than pre-hypothermic and cooling values during the rewarming 




8.3 Paper III 
In our third paper we investigated the intracellular distribution of Ca2+ between cytosol and 
mitochondria during hypothermia and rewarming in single, electrically stimulated cardiac 
myocytes. 
 
The cardiac myocytes appeared elongated without plasma membrane blebs. They responded 
well to field stimulation, and spontaneous contractions were rarely observed. Transient 
elevations in [Ca2+]mit consistently followed evoked [Ca
2+]cyt responses across all temperatures 
and throughout the experiments.  
 
8.3.1 Calibration Results 
In a set of experiments using the Fabiato program we found that Kd decreased with 
temperature and presumed change in pH for both fluo-3 and rhod-2. Therefore, fluorescence 
measurements were scaled according to the known change in Kd with temperature and 
presumed change in pH for each indicator.  
 
8.3.2 Baseline [Ca2+]mit and [Ca
2+]cyt 
Compared to control values at 37ºC pre-hypothermia, baseline [Ca2+]cyt and [Ca
2+]mit were 
significantly decreased at 15ºC (figure 4, paper III). After 30 min at 15ºC and with subsequent 
rewarming, [Ca2+]cyt tended to increase and baseline [Ca
2+]mit returned progressively to control 
(pre-hypothermia) levels. 
 
8.3.3 Evoked [Ca2+]mit and [Ca
2+]cyt responses 
Electrical stimulation evoked transient elevations of [Ca2+]cyt in cardiac myocytes that were 
matched by elevations of [Ca2+]mit. The peak of the evoked [Ca
2+]cyt responses decreased 
during hypothermia and returned to pre-hypothermic levels during rewarming (figure 5, paper 
III). The amplitude (peak minus baseline) decreased during hypothermia and rewarming as 
baseline tended to increase. In contrast, both the peak and amplitude of the evoked [Ca2+]mit 
responses were unchanged during hypothermia at 15ºC and rewarming. 
During hypothermia and after rewarming, electrical stimulation often evoked 
secondary [Ca2+]cyt and [Ca
2+]mit responses. These secondary [Ca
2+] responses were present in 






8.3.4 Time to peak [Ca2+]mit and [Ca
2+]cyt 
The time to peak of both [Ca2+]cyt and [Ca
2+]mit responses were markedly increased (~150 - 
230 %) during hypothermia at 15ºC compared to pre-hypothermic levels (figure 6a, paper III). 
With rewarming, the time to peak of both [Ca2+]cyt and [Ca
2+]mit responses returned to control 
(pre-hypothermia) levels. 
 
8.3.5 Time to 50% decay [Ca2+]mit and [Ca
2+]cyt 
The time to 50% decay of both evoked [Ca2+]cyt and [Ca
2+]mit responses were markedly 
increased (~200 - 300%) during hypothermia at 15ºC compared to control pre-hypothermia 
levels (figure 6b, paper III). With rewarming the time to 50% decay of both evoked [Ca2+]cyt 
and [Ca
2+]mit responses returned to pre-hypothermic values. 
As a result of the prolongation of the evoked [Ca2+] responses, the integrated [Ca2+]cyt 
and [Ca
2+]mit responses were markedly elevated during hypothermia at 15ºC compared to 
control pre-hypothermia levels (P<0.05). This prolongation reflected a hypothermia-related 






9. General discussion 
In the presented thesis we developed a method for measuring total cardiac [Ca2+]i with 
45Ca2+ 
technique. The results demonstrate that hypothermia-induced elevation of myocardial [Ca2+]i 
takes place in an intact animal, and the increase is not reversed by rewarming.  In the in vitro 
study, we found that during hypothermia mitochondrial buffer a possible excessive [Ca2+]cyt. 
  
9.1 Hypothermia-induced cytosolic Ca2+ loading 
The mechanism for cytosolic Ca2+ loading during hypothermia is not known and is likely 
multi-factorial. In cardiac myocytes the components regulating intracellular Ca2+ homeostasis 
are affected by temperature; the prevailing theory to explain hypothermia-induced elevation 
of [Ca2+]i is that the Na
+/K+-ATPase is markedly inhibited by cooling [27], Q10 coefficient 3,0 
[28], which leads to an elevation of [Na+]i. The rise in [Na
+]i may entail a reversed mode of 
the Na+-Ca2+ exchanger (NCX), Q10 coefficient 1,35 [13, 29], resulting in elevated Ca
2+ 
uptake [39]. The fact that the NCX is less affected by temperature than the Na+/K+ ATPase, 
makes this possibility likely. 
Hypothermia also increases the action potential duration [29, 97] and reduces the rate 
of inactivation of the Ca2+ current [13, 97, 98]. Moreover, hypothermia inhibits sarco-
/endoplasmic reticulum Ca2+ ATPase 2 (SERCA2) [30], and the rate of SR Ca2+ release per 
unit Ca2+ current is increased [32]. Among the Ca2+ extrusion mechanisms, sarcolemmal Ca2+ 
ATPase and the MCU are slowed by cooling [39]. These mechanisms may all elevate 
cytoplasmic Ca2+ at low temperatures.  
 
9.2 Consequences of prolonged hypothermia 
In paper II we found that cardiac [Ca2+]i after long-term hypothermia in vivo (15ºC, 4 hs) was 
substantially elevated from short-term hypothermia (15ºC, 0,5 h) (which was not significantly 
increased from normothermic control). This indicates that the time-aspect of exposure to 
hypothermia is crucial to [Ca2+]i, and that hypothermia in vivo does not induce an immediate 
rise in myocardial [Ca2+]i. This time-dependent elevation of [Ca
2+]i might be reflected by the 
observed reduction in contractile function -LVSP and LV dP/dtmax were all significantly 
lowered (21 - 50%) after 4 hs at 15ºC compared to 15ºC 0 min (paper II). The latter 
observations are supported by others [16, 17]. 
Conversely, it is well known that cooling in vitro rapidly elevates [Ca2+]i and [Ca
2+]cyt 
[13, 28, 29, 31, 32, 34, 35, 38, 99-104], and the results from paper III might also suggest that 
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hypothermia induces elevation of Ca2+ transients in single cardiac myocytes. The divergent 
findings in vivo and in vitro may be explained by the possibility that in vivo hearts better 
tolerate low temperature since in vitro hearts, or cells, are exposed to a dramatic change of 
their environment. However, according to table 2, the in vitro experiments show a smaller 
increase in [Ca2+]cyt when compared to the converted values from the in vivo hearts. Hence, 
the 45Ca2+ technique used in the in vivo experiments might not be sensitive enough to detect 
smaller changes of [Ca2+]i already evolving during the first minutes of hypothermia.  
Contractile failure induced by elevated [Ca2+]i is defined as “Ca
2+ overload” [46]. 
Based on our in vivo-results, we assume that calcium overload takes place during long-lasting 
hypothermia. Ca2+ overload is extensively studied following myocardial ischemia/reperfusion 
where Ca2+ overload is regarded an important substrate for reduced contractile function.  The 
underlying mechanisms are not clear, but the following are suggested to be involved are SR 
Ca2+ release to cytosol giving rise to [Ca2+]cyt oscillations/delayed after-depolarizations that 
may induce arrhythmias and myofibrillar hypercontracture [68, 105], reduced membrane 
potential and variation in action potential duration [106], [Ca2+]mit overload, dysfunction and 
damage (discussed in detail below) involving increase in ROS [22, 23] and impaired high 
energy phosphate homeostasis [17], and decreased myofilament Ca2+ sensitivity resulting 
from increased cTnI phosphorylation [24]. In addition, deep hypothermia itself prolongs SR 
Ca2+ release and reuptake over the cardiac cycle. This results in diastolic Ca2+ loading of the 
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9,3 
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  1,03* 
37ºC vs. 15ºC(40min) 
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  0,22*  
3,01 
  1,47* 
37ºC vs. 37ºC (rewarmed from 4hs 15ºC) 
[Ca2+]i [µmol (g dry wt)
-1] 







  0,17* 
0,55-2,33 
  0,27-1,14* 
1,97 
  0,97* 
37ºC vs. 15ºC (0,5 and 4 hs) 
[Ca2+]i [µmol (g dry wt)
-1] 
  [Ca2+]cyt [µmol/L cytosol]* 
  
Table 2: [Ca]i (µmol/L cytosol (bold)) or (µmol (g dry wt)
-1) and [Ca2+]cyt (µmol/L cytosol) 
before, during and after hypothermia in vitro and in vivo. * means conversion to [Ca2+]cyt, 
according to Bers [40]. However, this conversion might not correct for increased 
mitochondrial Ca2+ buffering. 
 
9.3 Mitochondrial Ca2+ buffering 
The mitochondrion is capable of storing enormous amounts of Ca2+ (up to 10,000 µM, table 1) 
bound to inorganic phosphate [50]. This way the free [Ca2+]mit is kept in the low µM range 
allowing a precise regulation of ATP production [50]. Due to this Ca2+ buffering, 
mitochondrial Ca2+ handling likely protects the cell against Ca2+ overload [50, 107-112]. 
According to table 2, hypothermia increases [Ca2+]i  by a factor of 4 and 7 during 
cooling [34, 113], but in isolated cardiac myocytes [Ca2+]cyt is only increased by 0,2 – 3,4 fold 
(17ºC, exposure-time unknown) [13]. This might reflect that the primary hypothermia-
induced increase of [Ca2+]cyt is buffered, and this is supported by the results from paper III.  
 In this paper, the observed elevation of transient [Ca2+]mit responses (time to peak and 
50% decay) may reflect that the mitochondria buffer hypothermia-induced excessive [Ca2+]cyt. 
Conversely,we found that baseline [Ca2+]mit is decreased during hypothermia which might 
support the fact that the MCU is markedly inhibited at lower temperature [39]. Hence, 
mitochondrial Ca2+ uptake should be decreased with cooling. Moreover, since time to 50% 
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decay of [Ca2+]mit was increased during hypothermia, it is likely that mitochondrial Ca
2+ 
extrusion through the NCLX is slowed, and this will, if anything, contribute to the elevation 
of [Ca2+]mit. 
Whether the observed mitochondrial Ca2+ buffering has consequences for 
mitochondrial function, with possible relation to hypothermia-induced contractile 
dysfunction, is not elucidated. In general, mitochondrial Ca2+ uptake activates mitochondrial 
ROS production [55, 68]. Ca2+ overload or increased ROS production may cause MPTP 
opening which leads to mitochondrial inner membrane permeabilization, membrane potential 
dissipation, impaired respiratory chain function, halt of mitochondrial ATP synthesis, 
organelle swelling, and outer membrane rupture [56, 58]. Ultimately the outcome will be loss 
of plasma membrane integrity and cell rupture characterized as necrotic cell death [57]. 
MPTP activation may also induce autophagy and cellular stress responses which is known to 
take place during rewarming from hypothermia [25]. Excessive activation of autophagy can 
also trigger autophagic cell death [109]. 
Hypothermia/rewarming in vivo is known to decrease ATP synthesis and damage 
mitochondrial ultra-structure [15, 16]. Cold perfusion (17ºC, 50 min) in isolated hearts 
attenuates electron transport and causes formation of ROS [22, 60]. These observations 
suggest that the mechanisms listed above also take place during hypothermia and rewarming 
due to mitochondrial Ca2+ buffering of excessive [Ca2+]cyt.  
 
9.4 Outcome of rewarming 
With respect to contractile function of the heart and the outcome from accidental 
hypothermia, the calcium homeostasis after rewarming is an important factor. In paper I and 
II, hypothermia-induced elevated [Ca2+]i persisted during rewarming and disclosed in concert 
with cardiac contractile dysfunction. The latter corresponds with earlier results from this 
model [16] and is supported by others [11, 12]. Contractile dysfunction during deep 
hypothermia and after rewarming is also reported as reduced maximal Ca2+-activated force 
and decreased twitch force in papillary muscle (15ºC) [24] and as reduced maximal Ca2+-
activated LVP and impaired relaxation in isolated hearts (17ºC) [13]. Contractile failure 
induced by elevated [Ca2+]i is defined as Ca
2+ overload [46]. Based on our results, we assume 
that Ca2+ overload takes place during and after rewarming. 
In paper III, the changes of time to peak and time to 50% decay of [Ca2+]cyt were 
normalized during rewarming. Baseline, however, first decreased during cooling but tended to 
increase during rewarming (figure 4, paper III). In cold perfused isolated hearts (10 – 15ºC, 40 
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min) a hypothermia-induced Ca2+ accumulation was only partially normalized following 
rewarming [28, 34, 35]. Transient responses of [Ca2+]mit in paper III were unaltered during the 
experiment (figure 5, paper III). Other researchers have reported that hypothermia-induced 
elevation of [Ca2+]mit, attenuated electron transport and moderate formation of ROS were 
reversed by rewarming and did not lead to functional impairment in cold perfused (17ºC, 50 
min) isolated hearts [22, 60]. 
The observed [Ca2+]mit decrease of time to peak and 50% decay during rewarming 
might indicate that mitochondria is releasing Ca2+ during rewarming. This may be caused by a 
NCLX release of Ca2+ as a consequence of restored function of pumps and exchangers, and 
normalized [Ca2+]cyt.   
The decrease in baseline of [Ca2+]mit during hypothermia and the unchanged amplitude 
does not support a possible increase of [Ca2+]mit. The in vitro hypothermia-protocols are fairly 
short-lasting with respect to in a clinical setting of accidental hypothermia. This leads us to 
speculate if our results in paper III, which partly indicates elevation [Ca2+]cyt and [Ca
2+]mit, 
were only a modest increase. In vivo, the hypothermia-induced increase of [Ca2+]i was 
detected after 4 hs and persisted during rewarming. After 0,5 h at 15ºC, no elevation of [Ca2+]i 
was detected. This might suggest that reducing time of cold exposure is crucial for preserving 
Ca2+ homeostasis and possibly for optimizing cardiac function during and after rewarming. 
In paper III we did not measure myocyte contractility, so we cannot absolutely relate 
the observed changes in [Ca2+]cyt and [Ca
2+]mit  to myocyte function. However, during 
hypothermia and rewarming we found decreased amplitude of [Ca2+]cyt, possibly symbolizing 
a reduction of evoked SR Ca2+ release. In more than 50% of our cells, spontaneous release of 
Ca2+ was observed as fluorescent waves and after-contractions during and after rewarming. 
This phenomenon is explained by the accepted mechanism of delayed after-depolarizations. 
The SR refills with Ca2+ from the previous beat and the RyR recovers from refractoriness, and 
the high luminal SR [Ca2+] causes local SR Ca2+ release events (Ca2+ sparks) [105]. Some 
cells also ceased to contract and underwent changes in morphology. These observations make 
it tempting to suggest that the impaired Ca2+ handling entails post-hypothermic contractile 
dysfunction also in vitro.  
 
9.5 Future directions 
Simultaneous recordings of cytosolic and mitochondrial Ca2+ signals are challenging. One 
major problem is that although rhod-2 accumulates predominantly in the mitochondria, some 
may remain in the cytosol and thus be affected non-specifically by [Ca2+]cyt changes [86]. In 
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separate studies where rhod-2 was loaded into cells together with MitoTracker Green, it was 
shown that rhod-2 fluorescence is predominantly co-localized with MitoTracker Green 
fluorescence. Other potential problems include the risk of cross-talk between rhod-2 and fluo-
3 given the marginal spectral overlap as well as dye leakage from the cells over the more than 
two hours course of our experiments. In future studies, we will explore cytosolic [Ca2+] and 
mitochondrial [Ca2+] separately as well as ratiometric alternatives to cytosolic [Ca2+] 
measurement such as the combination of fluo-4 and fura red. Another option is to define 
regions of interest within mitochondria (using mitotracker) and outside according to Delmotte 






10. Final conclusions 
The main objective of the present thesis was to investigate Ca2+ handling in cardiac tissue 
during profound hypothermia and rewarming. By measuring total Ca2+ content and 
Ca2+distribution between cytosol and mitochondria, we have elucidated the Ca2+ homeostasis 
during hypothermia and rewarming. The results might point out mechanisms behind the 
hypothermia-induced contractile dysfunction. 
 
The main conclusions, based on results from the experiments are:  
 
 Rewarming following 4 hs of profound hypothermia induces an almost seven-fold 
increase in intracellular myocardial tissue calcium content and a significant reduction 
in cardiac output and stroke volume. This indicates that hypothermia/rewarming-
induced calcium overload in the myocardium may contribute to the post-hypothermic 
myocardial failure. 
 
 In the intact, beating heart in vivo, cardiac Ca2+ overload evolves during long-lasting 
profound hypothermia, and the increase in [Ca2+]i remains unchanged during 
rewarming. These results indicate that the observed post-hypothermic Ca2+ overload in 
vivo is established during hypothermia, that duration of hypothermia is crucial to 
[Ca2+]i  and that the myocardial Ca
2+ overload is not reversed by rewarming. This adds 
to our understanding of the pathophysiology of hypothermia rewarming-induced 
contractile dysfunction.  
 
- During hypothermia, mitochondria buffer excessive [Ca2+]cyt. The results partly 
indicates that hypothermia induces elevation of [Ca2+]mit
 which is released to cytosol 
during rewarming. Hypothermia-induced accumulation of Ca2+mit
 may prevent a 
cytosolic Ca2+ overload but possibly also deteriorates mitochondrial function and 
energy production. These novel data elucidates the consistency between Ca2+ overload 
and mitochondrial function. However, the cause and effect relationship between 
hypothermia-induced changes in [Ca2+]mit and hypothermia-induced mitochondrial 
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